| |
DOG Congress Home
Invitation
Organization, Deadlines
Overview of the Congress
Scientific Programme
Opening Ceremony
Ceremony 150 Years of DOG
Thursday, 20.September
Friday, 21.September
Saturday, 22.September
Sunday, 23.September
Poster Sessions
Symposia
Courses
Satellite Programme
Information
Social Programme
Sponsors, Exhibitors
DOG Homepage
|
|
AbstractSO.07.10 VEGF inhibition by Avastin and Lucentis: More than dose-dependent neutralisation? Klettner A., Roider J. Universitätsklinikum Schleswig-Holstein, Campus Kiel, Augenheilkunde Objective: Comparison of the efficiency and mechanisms of VEGF inhibition by Avastin and Lucentis Methods: Adult retina-RPE-choroid organ cultures prepared from freshly slaughtered porcine eyes were cultivated in a perfusion chamber. On the second day of culture, tissues were treated with Avastin (0,25 mg/ml) or Lucentis (0,125 mg/ml), respectively. The supernatant was collected after various time points and VEGF content was measured by VEGF Elisa (Quantikine Immunoassay, R&D Systems). Results: Adult retina-RPE-choroid organ cultures constitutively secrete VEGF into the supernatant (200pg/cm2 RPE per hour). After treatment with Avastin or Lucentis, VEGF is no longer detectable in the supernatant by Elisa for at least 6 hours. Conclusions: In the perfusion chamber, media is completely exchanged after 1,5 h of culture. With the media, Lucentis and Avastin is washed out, too. As both substances are still effective after 6 h, a dose-dependent neutralisation of VEGF cannot be the only mechanism of VEGF inhibition. These results indicate that VEGF might have an influence on its own expression by a positive feedback loop. The binding of VEGF to its antibody might impede VEGF secretion by inhibiting such a positive feedback loop. Also, this might be an explanation as to why Avastin and Lucentis show similar beneficial effects.
|
|